{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:10:12Z","timestamp":1792444212674,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Chest Medicine"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.ccm.2021.12.005","type":"journal-article","created":{"date-parts":[[2022,2,27]],"date-time":"2022-02-27T06:06:03Z","timestamp":1645941963000},"page":"179-187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Future Directions in Bronchiectasis Research"],"prefix":"10.1016","volume":"43","author":[{"given":"Rosanel","family":"Amaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00eddia","family":"Perea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriol","family":"Sibila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccm.2021.12.005_bib1","doi-asserted-by":"crossref","first-page":"1700629","DOI":"10.1183\/13993003.00629-2017","article-title":"European Respiratory Society guidelines for the management of adult bronchiectasis","volume":"50","author":"Polverino","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2021.12.005_bib2","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1183\/13993003.01033-2015","article-title":"Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study","volume":"47","author":"Quint","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2021.12.005_bib3","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1183\/13993003.01888-2015","article-title":"Research priorities in bronchiectasis: a consensus statement from the EMBARC Clinical Research Collaboration","volume":"48","author":"Aliberti","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2021.12.005_bib4","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0140-6736(18)31767-7","article-title":"Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity","volume":"392","author":"Flume","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ccm.2021.12.005_bib5","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1183\/09031936.00078714","article-title":"Network medicine, multimorbidity and the lung in the elderly","volume":"44","author":"Faner","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2021.12.005_bib6","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1164\/rccm.201009-1414PP","article-title":"Addressing the complexity of chronic obstructive pulmonary disease: from phenotypes and biomarkers to scale-free networks, systems biology, and P4 medicine","volume":"183","author":"Agust\u00ed","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2021.12.005_bib7","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12931-019-1105-z","article-title":"Multi-level immune response network in mild-moderate chronic obstructive pulmonary disease (COPD)","volume":"20","author":"Cruz","year":"2019","journal-title":"Respir Res"},{"key":"10.1016\/j.ccm.2021.12.005_bib8","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(08)61452-X","article-title":"Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease","volume":"372","author":"Anderson","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ccm.2021.12.005_bib9","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/resp.12228","article-title":"Sputum colour in non-CF bronchiectasis: the original neutrophil biomarker","volume":"19","author":"Chalmers","year":"2014","journal-title":"Respirology"},{"key":"10.1016\/j.ccm.2021.12.005_bib10","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1136\/thorax.56.5.366","article-title":"Assessment of airway neutrophils by sputum colour: correlation with airways inflammation","volume":"56","author":"Stockley","year":"2001","journal-title":"Thorax"},{"key":"10.1016\/j.ccm.2021.12.005_bib11","first-page":"6","article-title":"Inflammation: a two-edged sword - the model of bronchiectasis","volume":"69","author":"Cole","year":"1986","journal-title":"Eur J Respir Dis"},{"key":"10.1016\/j.ccm.2021.12.005_bib12","first-page":"141","article-title":"Targeting proteases in cystic fibrosis lung disease Paradigms","volume":"201","author":"Mckelvey","year":"2020","journal-title":"Prog Potential"},{"key":"10.1016\/j.ccm.2021.12.005_bib13","doi-asserted-by":"crossref","first-page":"642503","DOI":"10.1155\/2015\/642503","article-title":"Neutrophilic bronchial inflammation correlates with clinical and functional findings in patients with Noncystic fibrosis bronchiectasis","volume":"2015","author":"Dente","year":"2015","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.ccm.2021.12.005_bib14","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1378\/chest.123.4.1240","article-title":"Neutrophil chemotactic activity of sputum from patients with COPD: role of interleukin 8 and leukotriene B4","volume":"123","author":"Beeh","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2021.12.005_bib15","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1164\/rccm.200208-829OC","article-title":"Sputum sol neutrophil elastase activity in bronchiectasis: differential modulation by syndecan-1","volume":"168","author":"Chan","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2021.12.005_bib16","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1165\/ajrcmb\/4.1.26","article-title":"Effects of human neutrophil elastase and Pseudomonas aeruginosa proteinases on human respiratory epithelium","volume":"4","author":"Amitani","year":"1991","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.ccm.2021.12.005_bib17","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1164\/rccm.201605-1027OC","article-title":"Neutrophil elastase activity is associated with exacerbations and lung function decline in bronchiectasis","volume":"195","author":"Chalmers","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2021.12.005_bib18","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00252-2018","article-title":"Personalised anti-inflammatory therapy for bronchiectasis and cystic fibrosis: selecting patients for controlled trials of neutrophil elastase inhibition","volume":"5","author":"Keir","year":"2019","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.ccm.2021.12.005_bib19","doi-asserted-by":"crossref","first-page":"2001702","DOI":"10.1183\/13993003.01702-2020","article-title":"Sputum neutrophil elastase in bronchiectasis: a Southern European cohort study","volume":"56","author":"Gramegna","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2021.12.005_bib20","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1164\/rccm.201812-2351OC","article-title":"Pregnancy zone protein is associated with airway infection, neutrophil extracellular trap formation, and disease severity in bronchiectasis","volume":"200","author":"Finch","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2021.12.005_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(20)30504-X","article-title":"Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study","author":"Keir","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ccm.2021.12.005_bib22","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nrm3904","article-title":"Remodelling the extracellular matrix in development and disease","volume":"15","author":"Bonnans","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.ccm.2021.12.005_bib23","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1152\/physrev.00022.2006","article-title":"Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted","volume":"87","author":"Greenlee","year":"2007","journal-title":"Physiol Rev"},{"key":"10.1016\/j.ccm.2021.12.005_bib24","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1513\/AnnalsATS.201411-513OC","article-title":"Matrix metalloproteinases vary with airway microbiota composition and lung function in non-cystic fibrosis bronchiectasis","volume":"12","author":"Taylor","year":"2015","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.ccm.2021.12.005_bib25","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1378\/chest.107.6.1641","article-title":"Human neutrophil collagenase (MMP-8), identified in bronchiectasis BAL fluid, correlates with severity of disease","volume":"107","author":"Sepper","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2021.12.005_bib26","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1183\/09031936.02.00282402","article-title":"Overexpression of matrix metalloproteinase-8 and -9 in bronchiectatic airways in\u00a0vivo","volume":"20","author":"Zheng","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2021.12.005_bib27","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1183\/09031936.00173210","article-title":"The role of matrix metalloproteinases in cystic fibrosis lung disease","volume":"38","author":"Gaggar","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2021.12.005_bib28","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/resp.12582","article-title":"Sputum matrix metalloproteinase-8 and -9 and tissue inhibitor of metalloproteinase-1 in bronchiectasis: clinical correlates and prognostic implications","volume":"20","author":"Guan","year":"2015","journal-title":"Respirology"},{"key":"10.1016\/j.ccm.2021.12.005_bib29","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1164\/rccm.200803-391OC","article-title":"MUC5B is the major mucin in the Gel phase of sputum in chronic obstructive pulmonary disease","volume":"178","author":"Kirkham","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2021.12.005_bib30","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1164\/rccm.201906-1219OC","article-title":"Airway mucus hyperconcentration in non\u2013cystic fibrosis bronchiectasis","volume":"201","author":"Ramsey","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2021.12.005_bib31","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/resp.12595","article-title":"Secreted mucins and airway bacterial colonization in non-CF bronchiectasis","volume":"20","author":"Sibila","year":"2015","journal-title":"Respirology"},{"issue":"4","key":"10.1016\/j.ccm.2021.12.005_bib32","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1159\/000512268","article-title":"Mucin secretion in cystic fibrosis \u2013 a systematic review","volume":"39","author":"Niv","year":"2020","journal-title":"Dig Dis"},{"key":"10.1016\/j.ccm.2021.12.005_bib33","doi-asserted-by":"crossref","first-page":"e1001067","DOI":"10.1371\/journal.ppat.1001067","article-title":"Antimicrobial peptides: Primeval molecules or future drugs?","volume":"6","author":"Peters","year":"2010","journal-title":"Plos Pathog"},{"key":"10.1016\/j.ccm.2021.12.005_bib34","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1378\/chest.15-1353","article-title":"Antimicrobial peptides and innate lung defenses: role in infectious and noninfectious lung diseases and therapeutic applications","volume":"149","author":"Hiemstra","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2021.12.005_bib35","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1183\/09031936.03.00098803","article-title":"Innate immunity in the lung: How epithelial cells fight against respiratory pathogens","volume":"23","author":"Bals","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2021.12.005_bib36","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1128\/IAI.73.3.1271-1274.2005","article-title":"Anti-inflammatory and antimicrobial roles of secretory leukocyte protease inhibitor","volume":"73","author":"Doumas","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.ccm.2021.12.005_bib37","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1136\/thoraxjnl-2018-212895","article-title":"Antimicrobial peptides, disease severity and exacerbations in bronchiectasis","volume":"74","author":"Sibila","year":"2019","journal-title":"Thorax"},{"key":"10.1016\/j.ccm.2021.12.005_bib38","article-title":"A\u00a0cluster Analysis of bronchiectasis patients based on the airway immune profile","author":"Perea","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2021.12.005_bib39","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.arbres.2019.12.017","article-title":"C-reactive protein concentration in Steady-state bronchiectasis: prognostic Value of future severe exacerbations. Data from the Spanish Registry of bronchiectasis (RIBRON)","volume":"57","author":"Posadas","year":"2021","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.ccm.2021.12.005_bib40","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1157\/13114651","article-title":"The association between bronchiectasis, systemic inflammation, and tumor necrosis factor alpha","volume":"44","author":"Mart\u00ednez-Garc\u00eda","year":"2008","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.ccm.2021.12.005_bib41","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1513\/AnnalsATS.201902-140RL","article-title":"Soluble P-selectin in acute exacerbations and stable bronchiectasis in adults","volume":"16","author":"M\u00e9ndez","year":"2019","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.ccm.2021.12.005_bib42","first-page":"2631","article-title":"Systemic inflammation during and after bronchiectasis exacerbations: impact of Pseudomonas aeruginosa","volume":"9","author":"Men\u00e9ndez","year":"2020","journal-title":"J\u00a0Clin Med"},{"issue":"8","key":"10.1016\/j.ccm.2021.12.005_bib43","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1513\/AnnalsATS.202002-094OC","article-title":"Thrombocytosis during stable state Predicts mortality in bronchiectasis","volume":"18","author":"Aliberti","year":"2021","journal-title":"Ann Am Thorac Soc Published Online J"},{"key":"10.1016\/j.ccm.2021.12.005_bib44","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.rmed.2017.04.009","article-title":"The heterogeneity of systemic inflammation in bronchiectasis","volume":"127","author":"Saleh","year":"2017","journal-title":"Respir Med"},{"key":"10.1016\/j.ccm.2021.12.005_bib45","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1126\/science.2772657","article-title":"Identification of the cystic fibrosis gene: Chromosome walking and jumping","volume":"245","author":"Rommens","year":"1989","journal-title":"Science"},{"issue":"10212","key":"10.1016\/j.ccm.2021.12.005_bib46","doi-asserted-by":"crossref","first-page":"P1940","DOI":"10.1016\/S0140-6736(19)32597-8","article-title":"Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial","volume":"394","author":"Harry","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ccm.2021.12.005_bib47","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1513\/AnnalsATS.201507-472OC","article-title":"Etiology of non-cystic fibrosis bronchiectasis in adults and its correlation to disease severity","volume":"12","author":"Lonni","year":"2015","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.ccm.2021.12.005_bib48","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1503\/cmaj.050774","article-title":"Epigenetics and human disease: translating basic biology into clinical applications","volume":"174","author":"Rodenhiser","year":"2006","journal-title":"CMAJ"},{"key":"10.1016\/j.ccm.2021.12.005_bib49","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nchembio.275","article-title":"Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis","volume":"6","author":"Hutt","year":"2010","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.ccm.2021.12.005_bib50","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1164\/rccm.201809-1651OC","article-title":"Airway bacterial load and inhaled antibiotic response in bronchiectasis","volume":"200","author":"Sibila","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2021.12.005_bib51","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02086-2016","article-title":"The microbiome in respiratory medicine: current challenges and future perspectives","volume":"49","author":"Faner","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2021.12.005_bib52","doi-asserted-by":"crossref","first-page":"2000769","DOI":"10.1183\/13993003.00769-2020","article-title":"Sputum neutrophil elastase associates with microbiota and Pseudomonas aeruginosa in bronchiectasis","volume":"56","author":"Oriano","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2021.12.005_bib53","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41591-021-01289-7","article-title":"Integrative microbiomics in bronchiectasis exacerbations","volume":"27","author":"Mac Aog\u00e1in","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.ccm.2021.12.005_bib54","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/resp.13106","article-title":"The past decade in bench research into pulmonary infectious diseases: what do clinicians need to know?","volume":"22","author":"Finch","year":"2017","journal-title":"Respirology"},{"key":"10.1016\/j.ccm.2021.12.005_bib55","doi-asserted-by":"crossref","first-page":"1602108","DOI":"10.1183\/13993003.02108-2016","article-title":"Pseudomonas aeruginosa adaptation and diversification in the non-cystic fibrosis bronchiectasis lung","volume":"49","author":"Hilliam","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2021.12.005_bib56","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1056\/NEJMsb1503104","article-title":"Precision medicine \u2014 personalized, problematic, and promising","volume":"372","author":"Jameson","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccm.2021.12.005_bib57","doi-asserted-by":"crossref","first-page":"1701655","DOI":"10.1183\/13993003.01655-2017","article-title":"Precision medicine in airway diseases: moving to clinical practice","volume":"50","author":"Agust\u00ed","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2021.12.005_bib58","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1183\/13993003.01359-2015","article-title":"Treatable traits: toward precision medicine of chronic airway diseases","volume":"47","author":"Agusti","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2021.12.005_bib59","doi-asserted-by":"crossref","first-page":"1801269","DOI":"10.1183\/13993003.01269-2018","article-title":"Treatable traits in bronchiectasis","volume":"52","author":"Boaventura","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2021.12.005_bib60","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S2213-2600(18)30053-5","article-title":"Bronchiectasis: new therapies and new perspectives","volume":"6","author":"Chalmers","year":"2018","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ccm.2021.12.005_bib61","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1056\/NEJMoa2021713","article-title":"Phase 2 trial of the DPP-1 inhibitor Brensocatib in bronchiectasis","volume":"383","author":"Chalmers","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccm.2021.12.005_bib62","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41572-018-0042-3","article-title":"Bronchiectasis","volume":"4","author":"Chalmers","year":"2018","journal-title":"Nat Rev Dis Prim"}],"container-title":["Clinics in Chest Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523121012521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523121012521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:14:42Z","timestamp":1759454082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272523121012521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0272523121012521"],"URL":"https:\/\/doi.org\/10.1016\/j.ccm.2021.12.005","relation":{},"ISSN":["0272-5231"],"issn-type":[{"value":"0272-5231","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Future Directions in Bronchiectasis Research","name":"articletitle","label":"Article Title"},{"value":"Clinics in Chest Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccm.2021.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}